MaxCyte, Inc. (LON:MXCT – Get Free Report) insider Stan Erck sold 47,689 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of GBX 388 ($5.19), for a total transaction of £185,033.32 ($247,503.10).
MaxCyte Stock Performance
LON:MXCT opened at GBX 280 ($3.75) on Friday. The company has a market capitalization of £294.25 million, a price-to-earnings ratio of -1,120.00 and a beta of 1.13. The business has a 50 day moving average of GBX 316.07 and a 200 day moving average of GBX 332.58. The company has a debt-to-equity ratio of 8.37, a current ratio of 14.31 and a quick ratio of 14.38. MaxCyte, Inc. has a 1-year low of GBX 180 ($2.41) and a 1-year high of GBX 430 ($5.75).
MaxCyte Company Profile
Featured Stories
- Five stocks we like better than MaxCyte
- How to Calculate Inflation Rate
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Investing in Construction Stocks
- MarketBeat Week in Review – 9/30 – 10/4
- Where to Find Earnings Call Transcripts
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.